Genpact Limited Form 8-K Summary
Business Context and Reporting Period
Genpact Limited, a Bermuda-incorporated company, filed this Form 8-K on May 7, 2026. The filing reports financial results for the three months ended March 31, 2026, pursuant to Item 2.02. The company's common shares trade on the New York Stock Exchange under the symbol "G".
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not detailed in the provided text.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative performance data.
Guidance, Outlook, and Risks
The company references non-GAAP financial measures in its press release and conference call, with reconciliations to GAAP measures provided in the attached exhibit. The filing includes standard disclaimers that the information is furnished and not deemed filed for purposes of Section 18 of the Exchange Act, limiting liability. No specific guidance, outlook, or risk factors are detailed in the text of this Form 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2026 revenue, earnings, and cash flow figures.
- Examine the reconciliation of non-GAAP to GAAP financial measures in the press release.
- Verify year-over-year growth rates and margin trends in the attached exhibit.
- Check for any updated forward-looking guidance or strategic initiatives mentioned in the press release.